550 related articles for article (PubMed ID: 26693947)
1. Loop diuretics, renal function and clinical outcome in patients with heart failure and reduced ejection fraction.
Damman K; Kjekshus J; Wikstrand J; Cleland JG; Komajda M; Wedel H; Waagstein F; McMurray JJ
Eur J Heart Fail; 2016 Mar; 18(3):328-36. PubMed ID: 26693947
[TBL] [Abstract][Full Text] [Related]
2. In chronic heart failure with marked fluid retention, the i.v. high doses of loop diuretic are a predictor of aggravated renal dysfunction, especially in the set of heart failure with normal or only mildly impaired left ventricular systolic function.
De Vecchis R; Ciccarelli A; Ariano C; Cioppa C; Giasi A; Pucciarelli A; Cantatrione S
Minerva Cardioangiol; 2011 Dec; 59(6):543-54. PubMed ID: 21330961
[TBL] [Abstract][Full Text] [Related]
3. Effects on survival of loop diuretic dosing in ambulatory patients with chronic heart failure using a propensity score analysis.
Dini FL; Ghio S; Klersy C; Rossi A; Simioniuc A; Scelsi L; Genta FT; Cicoira M; Tavazzi L; Temporelli PL
Int J Clin Pract; 2013 Jul; 67(7):656-64. PubMed ID: 23758444
[TBL] [Abstract][Full Text] [Related]
4. Impact of diuretic dosing on mortality in acute heart failure using a propensity-matched analysis.
Yilmaz MB; Gayat E; Salem R; Lassus J; Nikolaou M; Laribi S; Parissis J; Follath F; Peacock WF; Mebazaa A
Eur J Heart Fail; 2011 Nov; 13(11):1244-52. PubMed ID: 22024466
[TBL] [Abstract][Full Text] [Related]
5. Intravenous Diuretic Therapy for the Management of Heart Failure and Volume Overload in a Multidisciplinary Outpatient Unit.
Buckley LF; Carter DM; Matta L; Cheng JW; Stevens C; Belenkiy RM; Burpee LJ; Young MA; Weiffenbach CS; Smallwood JA; Stevenson LW; Desai AS
JACC Heart Fail; 2016 Jan; 4(1):1-8. PubMed ID: 26656139
[TBL] [Abstract][Full Text] [Related]
6. Outcomes Associated With a Strategy of Adjuvant Metolazone or High-Dose Loop Diuretics in Acute Decompensated Heart Failure: A Propensity Analysis.
Brisco-Bacik MA; Ter Maaten JM; Houser SR; Vedage NA; Rao V; Ahmad T; Wilson FP; Testani JM
J Am Heart Assoc; 2018 Sep; 7(18):e009149. PubMed ID: 30371181
[TBL] [Abstract][Full Text] [Related]
7. Higher doses of loop diuretics limit uptitration of angiotensin-converting enzyme inhibitors in patients with heart failure and reduced ejection fraction.
Ter Maaten JM; Martens P; Damman K; Dickstein K; Ponikowski P; Lang CC; Ng LL; Anker SD; Samani NJ; Filippatos G; Cleland JG; Zannad F; Hillege HL; van Veldhuisen DJ; Metra M; Voors AA; Mullens W
Clin Res Cardiol; 2020 Aug; 109(8):1048-1059. PubMed ID: 32002631
[TBL] [Abstract][Full Text] [Related]
8. Poor concordance between different definitions of worsening renal function in patients with acute exacerbation of chronic heart failure: a retrospective study.
De Vecchis R; Baldi C; Di Biase G
Minerva Cardioangiol; 2016 Apr; 64(2):127-37. PubMed ID: 25423291
[TBL] [Abstract][Full Text] [Related]
9. Loop diuretic dose adjustments after a hospitalization for heart failure: insights from ASCEND-HF.
DeVore AD; Hasselblad V; Mentz RJ; O'Connor CM; Armstrong PW; McMurray JJ; Ezekowitz JA; Tang WH; Starling RC; Voors AA; Califf RM; Hernandez AF
Eur J Heart Fail; 2015 Mar; 17(3):340-6. PubMed ID: 25619549
[TBL] [Abstract][Full Text] [Related]
10. Determinants of Diuretic Responsiveness and Associated Outcomes During Acute Heart Failure Hospitalization: An Analysis From the NHLBI Heart Failure Network Clinical Trials.
Kiernan MS; Stevens SR; Tang WHW; Butler J; Anstrom KJ; Birati EY; Grodin JL; Gupta D; Margulies KB; LaRue S; Dávila-Román VG; Hernandez AF; de Las Fuentes L;
J Card Fail; 2018 Jul; 24(7):428-438. PubMed ID: 29482026
[TBL] [Abstract][Full Text] [Related]
11. Tolvaptan Improves Prognosis in Responders with Acute Decompensated Heart Failure by Reducing the Dose of Loop Diuretics.
Nakamura M; Sunagawa O; Kinugawa K
Int Heart J; 2018; 59(1):87-93. PubMed ID: 29375117
[TBL] [Abstract][Full Text] [Related]
12. Renal function on admission modifies prognostic impact of diuretics in acute heart failure: a propensity score matched and interaction analysis.
Matsue Y; Shiraishi A; Kagiyama N; Yoshida K; Kume T; Okura H; Suzuki M; Matsumura A; Yoshida K; Hashimoto Y
Heart Vessels; 2016 Dec; 31(12):1980-1987. PubMed ID: 26892531
[TBL] [Abstract][Full Text] [Related]
13. Comparative effectiveness of loop diuretics on mortality in the treatment of patients with chronic heart failure - A multicenter propensity score matched analysis.
Täger T; Fröhlich H; Grundtvig M; Seiz M; Schellberg D; Goode K; Kazmi S; Hole T; Katus HA; Atar D; Cleland JGF; Agewall S; Clark AL; Frankenstein L
Int J Cardiol; 2019 Aug; 289():83-90. PubMed ID: 30827731
[TBL] [Abstract][Full Text] [Related]
14. Diuretic therapy as prognostic enrichment factor for clinical trials in patients with heart failure with reduced ejection fraction.
Coiro S; Girerd N; McMurray JJV; Pitt B; Swedberg K; van Veldhuisen DJ; Lamiral Z; Rossignol P; Zannad F
Clin Res Cardiol; 2021 Aug; 110(8):1308-1320. PubMed ID: 33956209
[TBL] [Abstract][Full Text] [Related]
15. Changes in Loop Diuretic Dose and Outcome After Cardiac Resynchronization Therapy in Patients With Heart Failure and Reduced Left Ventricular Ejection Fractions.
Martens P; Verbrugge FH; Nijst P; Dupont M; Mullens W
Am J Cardiol; 2017 Jul; 120(2):267-273. PubMed ID: 28532770
[TBL] [Abstract][Full Text] [Related]
16. Diuretic use and outcomes in patients with heart failure with reduced ejection fraction: Insights from the VICTORIA trial.
Ezekowitz J; Alemayehu W; Edelmann F; Ponikowski P; Lam CSP; O'Connor CM; Butler J; Corda S; McMullan CJ; Westerhout CM; Voors AA; Mentz RJ; Armstrong PW;
Eur J Heart Fail; 2024 Mar; 26(3):628-637. PubMed ID: 38450878
[TBL] [Abstract][Full Text] [Related]
17. Unloading therapy by intravenous diuretic in chronic heart failure: a double-edged weapon?
De Vecchis R; Ciccarelli A; Pucciarelli A
J Cardiovasc Med (Hagerstown); 2010 Aug; 11(8):571-4. PubMed ID: 20588135
[TBL] [Abstract][Full Text] [Related]
18. Comparison of the effects of combination diuretic therapy with oral hydrochlorothiazide or intravenous chlorothiazide in patients receiving intravenous furosemide therapy for the treatment of heart failure.
Kissling KT; Pickworth KK
Pharmacotherapy; 2014 Aug; 34(8):882-7. PubMed ID: 24990816
[TBL] [Abstract][Full Text] [Related]
19. Furosemide Prescription During the Dry State Is a Predictor of Long-Term Survival of Stable, Optimally Medicated Patients With Systolic Heart Failure.
Sargento L; Simões AV; Longo S; Lousada N; Reis RP
J Cardiovasc Pharmacol Ther; 2017 May; 22(3):256-263. PubMed ID: 27784799
[TBL] [Abstract][Full Text] [Related]
20. [Diuretic therapy in acute heart failure].
Trullàs JC; Morales-Rull JL; Formiga F
Med Clin (Barc); 2014 Mar; 142 Suppl 1():36-41. PubMed ID: 24930082
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]